Company Name: Nynomic AG ISIN: DE000A0MSN11   Reason for the research: Update Recommendation: Buy from: 13.11.2024 Target price: EUR 44.00 Target price on sight of: 12 months Last rating change: Analyst: Christian Sandherr Muted prel. Q3 in line with expectations // guidance confirmed Preliminary Q3 sales stood at € 24.3m, [ … ]

Company Name: Nynomic AG ISIN: DE000A0MSN11   Reason for the research: Update Recommendation: Buy from: 09.10.2024 Target price: EUR 44.00 Target price on sight of: 12 months Last rating change: Analyst: Christian Sandherr H2 marked by postponements, bright mid-term prospects; chg Topic: Nynomic cut its FY24 guidance due to del [ … ]

Company Name: Nynomic AG ISIN: DE000A0MSN11   Reason for the research: Update Recommendation: BUY from: 21.08.2024 Target price: EUR 50.00 Last rating change: Analyst: Christian Sandherr Q2 prelims: Improving margins despite weak top-line; chg. Topic: While Q2 sales was burdened by the challenging macro environment, Nynomic mana [ … ]

Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. Similar to FY23, this year’s operational performance should again be back-end loaded. Preliminary Q1 sales grew by 6.5% yoy to € 23m thanks to consolidati [ … ]

New product launched: Another building block for the mid-term Nynomic announced that its subsidiary Spectral Engines and Kraemer Elektronik, an expert for high quality testing systems of bulk solids for the pharmaceutical, chemical and food industry, have jointly developed and now presented a new product, the LabScanner Plus. While Kraemer El [ … ]

Strong Q4 profitability // conservative initial FY24 guidance; chg. Q4 sales increased by 5% yoy to € 34.6m (eNuW € 37.6m) as the company was able to book several development projects towards the end of the year, realized first revenues from larger plant phenotyping orders (Green Tech FY segment sales +44% yoy to ~ €25m) and over [ … ]

Strong Q4 expected // 2024 to be marked by significant growth Topic: Nynomic should report strong Q4 prelims. More importantly, FY24e should be marked by strong sales growth and further margin improvements as well as additional (potentially larger) acquisitions. Q4 sales are seen to come in at € 37.6m (+14% yoy; FY23e sales +4% yoy) than [ … ]